OpenAI Merges Apps into a Unified Super App
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 20 2026
0mins
Source: CNBC
- Super App Integration: OpenAI is merging its web browser, ChatGPT app, and Codex coding app into a single desktop super app, aimed at streamlining user experience and reducing product fragmentation, which is expected to enhance user satisfaction and efficiency.
- Leadership Changes: OpenAI's CEO of Applications, Fidji Simo, will oversee this integration alongside President Greg Brockman, indicating a high-level commitment to product consolidation that aims to strengthen the company's competitive position in the market.
- Focus on High Productivity: During an all-hands meeting, Simo emphasized that the company is “orienting aggressively” towards high-productivity use cases, demonstrating OpenAI's commitment to enhancing product focus and execution capabilities in the face of competition.
- IPO Prospects: As OpenAI prepares for a potential IPO, Simo, who took over the applications business in May, has been stressing product focus and discipline, signaling that the company will undertake more strategic initiatives to attract investors in the near future.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MSFT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MSFT
Wall Street analysts forecast MSFT stock price to rise
34 Analyst Rating
32 Buy
2 Hold
0 Sell
Strong Buy
Current: 460.520
Low
500.00
Averages
631.36
High
678.00
Current: 460.520
Low
500.00
Averages
631.36
High
678.00
About MSFT
Microsoft Corporation is a technology company. The Company develops and supports software, services, devices, and solutions. The Company’s segments include Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment consists of products and services in its portfolio of productivity, communication, and information services. This segment primarily comprises: Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of server products and cloud services, including Azure and other cloud services, SQL Server, Windows Server, Visual Studio, System Center, and related Client Access Licenses (CALs), and Nuance and GitHub; and Enterprise Services, including enterprise support services, industry solutions and Nuance professional services. The More Personal Computing segment primarily comprises Windows, Devices, Gaming, and search and news advertising.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Stock Price Increase: Microsoft shares rose 2.3% in Monday's trading, outperforming the S&P 500's 0.3% gain and the Nasdaq's 0.6% increase, indicating strong market performance and investor confidence in future growth prospects.
- Analyst Rating Upgrade: Citizens initiated coverage on Microsoft with an outperform rating and a one-year price target of $550 per share, with analysts believing the company holds a compelling position in the AI market and can benefit from evolving tech trends.
- Price Target Revision: Wells Fargo reiterated its overweight rating on Microsoft, raising its one-year price target from $625 to $650 per share, noting that the company is not receiving enough credit for its AI strengths and has potential to improve its positioning in certain categories.
- Upcoming Product Launches: Microsoft is expected to unveil several new AI software offerings at its Build conference this week, including a coding assistant aimed at enhancing its competitive edge, and despite recent gains, the stock remains down approximately 5% year-to-date, suggesting long-term investment potential.
See More
- Strong Earnings Report: NVIDIA's Q1 2026 adjusted EPS reached $1.87, more than doubling year-over-year, with sales hitting $81.6 billion, an 85% increase, showcasing the company's robust growth trajectory.
- Record Data Center Sales: Data center sales reached $75.2 billion, up 92% year-over-year, indicating strong market demand for its GPUs and further solidifying NVIDIA's leadership in the AI sector.
- Superchip Launch: The newly unveiled RTX Spark superchip integrates a high-performance 20-core CPU with the Blackwell graphics engine and up to 128GB of shared memory, set to provide desktop-grade supercomputing power for premium laptops from major brands, revolutionizing Windows PCs for the AI era.
- Optimistic Market Outlook: Although stock performance has slowed, the company's near-term earnings outlook remains positive, reflecting sustained strong demand in the AI and data center markets.
See More
- Market Uptrend: The S&P 500 rose 0.13% on Tuesday, marking its ninth consecutive day of gains, the longest streak since last May, and is up 20% from March lows, indicating a robust market recovery.
- Job Data Focus: ADP is set to release May payroll numbers on Wednesday, with economists expecting a gain of 110,000 jobs, slightly above April's 109,000, as investors watch for implications on the Fed's policy direction.
- Tech Stock Surge: HPE shares soared 19.5% on Tuesday, the largest jump since its 2015 spin-off, driven by strong AI-related demand, and are up 133% year-to-date, reflecting robust market demand and investor confidence.
- Cryptocurrency Decline: Bitcoin fell below $70,000, hitting its lowest level since April, alongside Ethereum dropping below $2,000, showcasing the volatility in the crypto market and cautious investor sentiment.
See More
- Gates Foundation Sells Microsoft: Bill Gates has gradually sold off his Microsoft shares over 25 years, completing the final sale in Q1 2023, which may impact the stability of his investment portfolio as he exits a major tech position.
- New Investment Emerges: The foundation initiated a position in West Pharmaceutical Services last quarter, a leading manufacturer of injectable drug delivery systems, indicating confidence in its potential to become a future Dividend King, reflecting a strategic shift in investment focus.
- Earnings Growth Forecast: West Pharmaceutical is projected to report earnings per share (EPS) of $8.62 and $9.55 in 2026 and 2027, respectively, representing a 14% to 15% growth compared to the forecast EPS of $7.29 for 2025, showcasing its resilience in a recession-resistant industry.
- Dividend Growth Potential: Although the current dividend yield is under 0.3%, West has increased its dividend for 32 consecutive years, suggesting that strong earnings growth and a potential resurgence in dividend growth could yield significant total returns for both dividend and growth investors in the long run.
See More
- Strong Market Performance: The S&P 500 rose by 0.13%, the Dow Jones by 0.45%, and the Nasdaq 100 by 0.48%, with all three indices reaching new all-time highs, reflecting strong investor confidence in tech stocks amid a surge in AI investments.
- Marvell Technology Soars: Marvell Technology's stock surged over 32% after Nvidia CEO Jensen Huang predicted the company would be the next to achieve a $1 trillion valuation, significantly boosting investor confidence in its future growth prospects.
- Hewlett Packard Enterprise's Strong Earnings: Hewlett Packard Enterprise's stock jumped more than 19% after reporting Q2 adjusted EPS of 79 cents, well above the consensus estimate of 54 cents, and raising its full-year adjusted EPS forecast to $3.35-$3.45, reflecting robust demand driven by AI.
- Labor Market Strength: US April JOLTS job openings unexpectedly rose by 731,000 to a 23-month high of 7.618 million, surpassing expectations of a decline to 6.866 million, indicating resilience in the labor market and further propelling stock market gains.
See More
- Microsoft Exit: The Gates Foundation Trust completed its final sale of Microsoft stock in Q1 2023, marking the end of a long-term investment in the tech giant and indicating a strategic shift in asset allocation.
- New Investment: The foundation added West Pharmaceutical Services to its $31 billion portfolio, a lesser-known healthcare stock that presents promising dividend growth potential, appealing to long-term investors seeking stability.
- Earnings Growth Forecast: West Pharmaceutical is projected to achieve earnings per share of $8.62 and $9.55 in 2026 and 2027, respectively, reflecting a 14% to 15% growth from the 2025 forecast of $7.29, suggesting a potential earnings growth surge ahead.
- Dividend Growth Potential: Although West's current forward dividend yield is under 0.3%, its 32-year history of increasing dividends indicates strong return potential, with future earnings growth likely to enhance dividend payouts significantly.
See More











